Healthcare Investment Insights: Navigating Recent Developments

Healthcare Investment Insights: Navigating Recent Developments


Join us for an exclusive briefing tailored for our top private equity (PE) clients, where we will explore recent developments shaping the healthcare industry and their impact on PE investments.

The McDermott team will provide in-depth insights into three critical areas: antitrust matters, emerging transaction approval requirements and essential healthcare compliance updates, and will share key strategies to successfully navigate this complex landscape.

During this dynamic session, you’ll have the opportunity to engage with our experienced PE, antitrust, healthcare and litigation lawyers experts, participate in a dedicated Q&A session and network with your peers at a cocktail reception. Don’t miss this chance to connect, learn and stay at the forefront of the ever-evolving healthcare industry.

To register, please contact Sydney Sparks.

Event Information

November 16, 2023 | 2:00 – 5:30 pm ET
Training | 2:00 – 4:00 pm ET
Networking Reception | 4:00 – 5:30 pm ET

McDermott Will & Emery
One Vanderbilt Avenue
New York, NY 10017


  • State Material Transaction Developments: Investors and dealmakers should take note of the increasing number of states passing or proposing laws that can require certain healthcare entities to provide notice of material transactions to state attorneys general or other regulators. Our team breaks down how this may impact your business and how you can plan ahead.
    • Speakers: Sarah Kitchell, Partner and Steven Schnelle, Partner
  • Antitrust and Hart-Scott-Rodino Act Outlook: FTC and DOJ’s proposed revised merger guidelines signal the Biden administration’s continued aggressive antitrust enforcement stance. Get up to speed on what this means for health industry deals and what investors should know for future M&A health transactions.
    • Speakers: Gregory Heltzer, Partner and Elai Katz, Partner
  • Compliance and Risk Management Amid Increased Scrutiny: Investors in the healthcare industry are in government (and whistleblower) crosshairs now more than ever. We’ll discuss areas to focus your proactive compliance efforts and why training for investment professionals and board members is critical to minimize risks for sponsors and portfolio companies.
    • Speakers: Laura McLane, Partner, Monica Wallace, Partner and Rita Ratner, Managing Director, Farragut Square Group

Dig Deeper

New York, NY / McDermott Event / October 17, 2024

HPE NYC 2024

London, United Kingdom / McDermott Event / September 19, 2024

HPE Europe 2024

Chicago, IL / McDermott Event / September 12, 2024

Chicago Boot Camp for Private Equity Professionals 2024

New York, NY / McDermott Event / October 16, 2024

Hospitals and Health Systems Summit 2024

Get In Touch